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Background: The aims of this study were to evaluate the clinical utility of multiplex ligation-dependent probe
amplification (MLPA) and array comparative genomic hybridization (aCGH) analyses on prenatal cases and to review
prenatal ultrasound findings of cytogenomic syndromes.
Results: Of the 54 prenatal cases analyzed, cytogenomic abnormalities were characterized in 14 cases. In four fetuses
with abnormal ultrasound findings, a 40.701 Mb duplication of 8q22.3-q24.3 and a 23.839 Mb deletion of 7q33-q36.3
derived from a paternal balanced translocation, a de novo 13.062 Mb deletion of 11q24.1-q25 for Jacobsen syndrome,
a de novo 19.971 Mb deletion of 7q11.23-q21.3 for type 1 split-hand/foot malformation (SHFM1), and a de novo
28.909 Mb duplication of 3q21.1-q25.1 were detected. A 699.8 Kb deletion at 5p15.33 for Cri du Chat syndrome
was confirmed in a fetus with abnormal MLPA result. A fetus with abnormal maternal screening was detected
with a de novo distal 1.747 Mb duplication at 2q37.1-q37.2 and a 6.664 Mb deletion at 2q37.2-q37.3. Of the eight
cases referred by history of spontaneous abortions, derivative chromosomes 11 from paternal carriers of a balanced
8q/11q and a 10q/11q translocation were noted in two cases, simple aneuploids of trisomy 2 and trisomy 21 were seen
in three cases, and compound aneuploids of two or three chromosomes were found in three cases. Post-test genetic
counseling was performed with detailed genomic information and well characterized postnatal syndromic features.
Conclusions: These results demonstrated that coupling MLPA screening and aCGH analysis are a cost-effective
approach to detect cytogenomic abnormalities in a prenatal setting. The aCGH analysis provided not only genomic
maps of breakpoints and gene content of imbalanced regions but also better inference of related phenotypes for
genetic counseling. Prenatal ultrasound findings reported in the literature for Jacobsen syndrome, SHFM and Cri du
Chat syndrome were summarized for use as diagnostic references.
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Prenatal genetic diagnosis has been driven by innovative
technologies and accumulated clinical knowledge. Since
late 1970s, invasive amniocentesis of amniotic fluid (AF)
and chorionic villus sampling (CVS) procedures, non-
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unless otherwise stated.ultrasound examination have been introduced and become
the standard of care in prenatal diagnosis. The major clin-
ical indications for prenatal diagnosis include advanced
maternal age (AMA) for increased risk of Down syndrome,
abnormal maternal serum screening (aMSS), abnormal
ultrasound (aUS) findings, family history (FH) of chromo-
somal or genetic disorders, history of spontaneous abortion
(hSAB), and recently integrated maternal serum fetal DNA
sequencing for aneuploidy screening [1-4]. In a retro-
spective study, advances in maternal serum screeningThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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decline in AF and CVS procedures, while the diagnostic
yield for chromosomal abnormalities increased from 2%
in 1991 to 7% in 2002 [2]. A recent report of prenatal
cases from 2007 to 2009 showed an abnormality detection
rate of 10.2% for numerical chromosomal abnormalities
and 1.9% for structural chromosomal abnormalities [3].
However, routine prenatal cytogenetic analysis has two
obvious limitations: the low analytical resolution of about
5–10 megabase (Mb) by the Giemsa banding and the long
turn-around time due to the in vitro cell culture proce-
dures. Various DNA-based molecular approaches have
been introduced to provide rapid prenatal screening and
diagnosis. Fluorescence in situ hybridization (FISH) using
labeled DNA probes in the size of 100–800 kilobase (Kb)
has enhanced the analytical resolution and allowed rapid
screening of locus-specific numerical aberrations. A multi-
plex FISH panel with differentially labeled probes was
developed for prenatal screening of common aneuploidies
of chromosomes X, Y, 13, 18 and 21 [5]. Quantitative
fluorescence-polymerase chain reaction (QF-PCR) had
been introduced for prenatal diagnosis of fetal aneuploids
[6,7]. Multiplex ligation-dependent probe amplification
(MLPA) was validated as a rapid, cost-effective and multi-
allelic approach for prenatal screening of common aneu-
ploids, recurrent genomic disorders and subtelomeric
imbalances [8-11]. For pediatric patients with intellectual
and developmental disabilities, genome-wide array com-
parative genomic hybridization (aCGH) using synthesized
oligonucleotides has been validated and recommended as
first tier genetic testing [12-14]. Extended application of
this aCGH analysis on prenatal diagnosis has been effect-
ive in defining gene content of chromosomal imbalances
and in detecting genomic disorders and cryptic aberrations
[15-17]. However, there are technical challenges and clinical
concerns for rapid replacement of prenatal cytogenetics with
genomic analysis [18]. In the technical front, proper DNA
extraction avoiding maternal cell contamination, cautious
on confined-placental mosaicism, and timely confirmatory
and follow up parental analyses need to be considered.
While in the clinical part, the benefit, limitations and pos-
sible outcomes should be discussed in pre- and post-testing
genetic consulting. In this study, we present an approach
coupling MLPA and aCGH analyses for prenatal detection
of cytogenomic abnormalities. Fourteen prenatal cases with
chromosomal rearrangements and submicroscopic abnor-
malities were defined and genetic counseling was conducted
with more detailed genomic characteristics. We also
reviewed prenatal ultrasound findings reported in literature
for Jacobsen syndrome, SHFM1 and Cri du Chat syndrome.
Results
The workflow of MLPA screening and routine karyotyping
for all prenatal referrals and aCGH analysis on selectedcases was shown in Figure 1. A total of 54 patients (18
cases with aUS, 13 by FH, 12 with hSAB, four with aMSS,
four with hSAB and FH, one with aUS and aMSS, one with
aUS and FH, and one with normal US/aMSS/FH but ab-
normal MLPA result) were elected to have further aCGH
analysis. The karyotyping, MLPA screening and aCGH
results of 14 abnormal cases and participated parents
are summarized in Table 1. The patient history, detailed
prenatal clinical findings and cytogenomic results for each
case are described as follows:
Case 1
Amniocentesis was performed because of multiple mal-
formations detected at 12 weeks of gestation. The ultra-
sonographic examination revealed fetal growth retardation,
bilateral cleft lip and palate, right-sided aortic arch, mul-
tiple cystic hypoplasias. MLPA analysis indicated a subtelo-
meric duplication of 8q and a subtelomeric deletion of 7q.
Chromosome analysis performed on cultured amnio-
cytes showed a derivative chromosome 7 from a trans-
location between chromosomal bands 7q33 and 8q22.3.
Further aCGH analysis revealed a 40.701 Mb duplication
of 8q22.3-q24.3 (105,474,143-146,175,291) including genes
from DPYS to ZNF16 and a 23.839 Mb deletion of 7q33-
q36.3 (134,972,470-158,811,468) including genes from
NUP205 to VIPR2. Follow up chromosome analysis on
both parents detected the father as a carrier of a balanced
translocation of 7q33/8q22.3.
Case 2
Amniocentesis was performed because congenital heart de-
fect was detected at 24 weeks of gestation. A four chamber
view showed single ventricle, single atrium and common
atrioventricular valve (Figure 2A). MLPA analysis detected
a subtelomeric deletion of 11q (Figure 2B). Further
aCGH analysis of DNA from cultured amniocytes re-
vealed a 13.062 Mb deletion of 11q24.1-q25 (121,377,483-
134,439,406) including genes from BC089451 to AK130852;
chromosome analysis performed on cultured amniocytes
showed an 11q23.3 deletion (Figure 2C). Parental chromo-
some analysis showed normal results. The parents elected
pregnancy termination.
Case 3
Amniocentesis was performed at 28 weeks gestation be-
cause of ultrasound detected anomalies of split-hand split-
foot malformation and multiple umbilical cord cysts
(Figure 3A). MLPA performed on DNA extracted from
non-cultured aminiocytes showed normal result. Further
aCGH analysis of DNA from cultured amniocytes revealed
a 19.971 Mb deletion of 7q11.23-q21.3 (76,539,754-
96,510,594) including genes from CCDC146 to DLX5;
chromosome analysis performed on cultured amniocytes
confirmed the 7q11.23-21.3 deletion (Figure 3B). Parental
Figure 1 A workflow showing an integrated MLPA screening, Karyotyping and aCGH analysis for prenatal diagnosis of cytogenomic
abnormalities. AMA, advanced maternal age; FH, family history of genetic disorders; aUS, abnormal ultrasound findings; hSAB, history of spontaneous
abortion.
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elected pregnancy termination. The postmortem exam-
ination showed the deformities of the hands and feet
(Figure 3C).Case 4
Amniocentesis was performed at 23 weeks gestation be-
cause of ultrasound detected anomalies of an increased
nuchal translucency (NT) and fetal growth retardation.
MLPA performed on DNA extracted from non-cultured
aminiocytes showed normal result. Further aCGH analysis
of DNA from cultured amniocytes revealed a 28.909 Mb
duplication of 3q21.1-q25.1 (124,410,610-153,319,948) in-
cluding genes from SEC22A to SUCNR1. Chromosome
analysis performed on cultured amniocytes confirmed
the 3q21.1-q25.1 duplication. Parental chromosome ana-
lysis showed normal results. The parents elected pregnancy
termination.Case 5
Amniocentesis was performed because of abnormal MLPA
result of a deletion in the Cri du Chat region. Ultrasound
examination at 18 weeks gestation found a normal result.
Chromosome analysis of cultured amniocytes showed a
normal result. Follow-up aCGH analysis revealed a 699.8
Kb deletion at 5p15.33 (711,361-1,411,206) including genes
TPPP, ZDHHC11, BRD9, TRIP13, NKD2, SLC12A7,
SLCA19, SLC6A18, TERT and CLPTM1L. The parents
decided to continue the pregnancy and the fetus was
delivery at term. Follow up communication to the mother
suggested that the girl appeared normal at age of two years.
Case 6
Amniocentesis was performed at 22 gestational weeks be-
cause of the abnormal second trimester screening result
suggesting an increased risk for Down’s syndrome. MLPA
performed on DNA extracted from non-cultured ami-
niocytes detected a subtelomeric deletion of 2q and
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revealed a 2q37 deletion. Further aCGH analysis of DNA
from cultured amniocytes revealed a 1.747 Mb duplication
at 2q37.1-q37.2 (234,210,736-235,957,912) including genes
from UGT1A8 to SH3BP4 and a 6.664 Mb deletion at
2q37.2-37.3 (236,012,851-242,677,269) including genes
from AGAP1 to PDCD1. Parental chromosome analysis
showed normal results. The parents elected pregnancy
termination.
Case 7
CVS was performed because of the hSAB and absence
of fetal heart by ultrasound examination at 8 weeks ges-
tation. The woman had aborted seven times, including six
times of fetal anomalies in earlier gestational period and
one induced labor due to the malformation at 28 gesta-
tional weeks (Figure 4A). MLPA analysis performed on
DNA extracted directly from CVS detected a subtelomeric
duplication of 8q and a subtelomeric deletion of 11q
(Figure 4B). Further analysis using aCGH revealed a
20.608 Mb duplication of 8q24.13-q24.3 (125,657,117-146,265,147) including genes from MTSS1 to C8orf33 and
an 18.082 Mb deletion of 11q23.3-q25 (116,350,093-
134,432,412) including genes from KIAA0999 to B3GAT1
(Figure 4C). Chromosome analysis on cultured fibroblasts
from the villi detected the derivative chromosome 11;
follow up parental chromosome analysis showed a normal
female karyotype in the mother and a balanced transloca-
tion between chromosomal bands 8q24.13 and 11q23.5 in
the father.Case 8
CVS was performed because of hSAB and absence of
fetal heart by ultrasound examination at 8 weeks gestation.
MLPA analysis indicated a subtelomeric duplication of 10q
and a subtelomeric deletion of 11q. Further aCGH ana-
lysis revealed a 9.067 Mb duplication of 10q26.13-q26.3
(126,217,300-135,284,309) including genes from LHPP
to SYCE1 and a 12.110 Mb deletion of 11q24.1-q25
(122,322,510-134,432,465) including genes from C11orf63
to B3GAT. Follow up parental chromosome analysis found
AB
C
Figure 2 Ultrasound findings and chromosomal abnormality characterized in case 2. A. A four chamber view shows single ventricle (SV),
single atrium (SA) and common atrioventricular valve. A color Doppler flow image shows the bloodstream of atrioventricular valve was flowed
from SV to SA. B. MLPA shows an 11q deletion (arrow). C. aCGH reveals a 13.062 Mb deletion of 11q24.1q25 (inset, arrow points to the distal
deleted chromosome 11).
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tween chromosomal bands 10q26 and 11q24.
Cases 9–14
CVS was performed because of hSAB for the six patients.
MLPA analyses detected XXY sex chromosome and three
copies of chromosomes 21 and 22 in patient 9, XXY sex
chromosome and three copies of chromosome 10 in pa-
tient 10, three copies of chromosomes 8 and 21 in patient
11, three copies of chromosome 2 in patients 12 and 13,
and three copies of chromosome 21 in patient 14. Follow
up aCGH analyses confirmed the MLPA results for all six
patients and ruled out other submicroscopic abnormal-
ities. Parental chromosome analyses on all of them found
normal results.
Discussion
Prenatal genetic counseling for detected cytogenomic ab-
normalities involves first the assessment of fetal viability
and second the prediction of severity of phenotype from
the family history and the clinical evidence in the literature.Of the 14 cases with defined cytogenomic abnormalities,
four had aUS findings, one was noted from abnormal
MLPA result, one was due to aMSS and eight were referred
by hSAB. Cytogenomic abnormalities detected in four cases
with aUS findings allowed further evaluation of genotype-
phenotype correlation. A large 40.701 Mb duplication of
8q22.3-q24.3 and a large 23.839 Mb deletion of 7q33-q36.3
were found in case 1. The large segmental imbalances likely
explain the observed malformations. A large 13.062 Mb de-
letion of 11q24.1-q25 was found in case 2, which is diag-
nostic for Jacobsen syndrome (OMIM#147791). A recent
study found that targeted deletion of the ETS1 gene results
in ventricular septal defects and abnormal ventricular
morphology in mice [19]. The ETS1 gene at 11q24.3 is
within the large 11q deletion of cases 2 and its haploin-
sufficiency likely explains the prenatally detected heart
defects. The 7q11.23-q21.3 deletion in case 3 is diagnostic
for the prenatally detected SHFM1 (OMIM#183600). In
case 5, aCGH analysis revealed a 699.8 Kb deletion includ-
ing the TERT gene (telomerase reverse transcriptase) at
5p15.33. This is a submicroscopic deletion undetectable
AC
B
Figure 3 Ultrasound findings and chromosomal abnormality characterized in case 3. A. The ultrasonography shows split-hand split-foot
malformation. B. aCGH reveals a 19.971 Mb deletion of 7q11.23q21.3 (inset, arrow points to the interstitial deleted chromosome 7). C. The induced
abortion shows split-hand split-foot malformation.
B
CA
Figure 4 Chromosomal structural rearrangement characterized in case 6. A. Pedigree shows the father (I-1) as a carrier for an 8q/11q balanced
translocation and the tested fetus (II-8) and previous abortions likely resulting from unbalanced recombinants. B. MLPA shows an 8q duplication and
an 11q deletion (arrows). C. aCGH reveals a 20.608 Mb duplication of 8q24.13q24.3 and an 18.082 Mb deletion of 11q23.3q25 (arrows).
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reported as a candidate gene for Cri du Chat syndrome
(OMIM#123450); the most important clinical features are
a high-pitched cat-like cry, distinct facial dysmorphism,
microcephaly, severe psychomotor and mental retardation
[20,21]. However, the normal prenatal ultrasound finding
and appear normal development at age of two years in
case 5 may represent a mild phenotype. This case raises
concern on prenatal genetic counseling of known micro-
deletion syndrome. A longitudinal study on this case is
recommended to the parents. Prenatal ultrasound findings
reported in literature for Jacobsen syndrome [22-26],
SHFM [27-30] and Cri du Chat syndrome [31-36] are
reviewed and summarized in Table 2. For Jacobsen syn-
drome, prenatal ultrasound showed heterogeneous findings
but hypoplastic heart defect or ventricular anomalies have
been observed at gestational age from 20 ~ 28 weeks; and
a distal deletion of 11q23 was found in all cases (Table 2)
[22-26]. For limb deficiencies, an earlier report of prenatal
diagnosis of ectrodactyly observed the ‘lobster claw’ anom-
aly in two cases and also reviewed three case reports in the
literature. However, the genetic etiology for these cases was
unknown [37]. The EUROSCAN study of limb reduction
deficiencies found that limb reduction deficiencies were
seen in 0.035% of pregnancies. Of the 54 cases studied byTable 2 Abnormal ultrasound findings in Jacobsen syndrome
Syndrome Gastational age Abnormal ultrasound findings
Jacobsen 20 wks Nuchal thickening (NT)
20 wks Unilateral duplex renal system, pyelectasis, o
20 wks Fetal biometry ~22 wks, short femurs and h
18 wks Unremarkable
20 wks Cerebral ventricular dilatation
28 wks
Hydronephrosis, hypoplastic lefft hear synd
skull of trigonocepholy.
24 wks Single ventricle, single atrium, atrioventricul
SHFM 12-15-19 wks NT 1.0 mm, single digit hand, two-digit spli
11-16 wks Irregular shaped hands with missing digits,
19 wks
Bilateral Cleft Lip/palate, median clefts of bo
oligodactyly.
15-29 wks
7 bilateral anomalies (3 both hands and foo
hands and 2 only foot) and 3 unilateral ano
28 wks Split hand/split foot, umbilical cord cysts.
Cri du Chat
16 wks
Pleural effusion, ascites, skin edema, hypopl
ventricular septal defect, cystic lesion in nuc
15+2 wks Moderate biparietal cerebral ventriculomeg
19 wks Boderline microcephaly
18+6 wks Encephalocele
21+3 wks Absent nasal bone
13 wks NT 1.6 mm, hypoplastic nasal bone (1.8 mm
18 wks Normalchromosome analysis, about 30% (16/54) were detected
with a chromosomal abnormality including trisomies 18
and 21, Klinefelter syndrome and a 7q deletion [38]. This
EUROSCAN result indicated that the limb deficiencies
could be an indicator for chromosomal abnormalities.
Review reports of prenatal ultrasound findings for SHFM
noted the detection of bilateral or unilateral split hand
foot malformations at gestational age from 11–29 weeks; a
TP63 gene mutation, a 22q11.2 deletion for DiGeorge syn-
drome and a 7q31 deletion was noted in three cases and
the genetic etiology for ten cases remained unknown
(Table 2) [27-30]. For Cri du Chat syndrome caused by a
5p deletion, pleural effusion, cerebral ventricular anomal-
ies, hypoplastic or absent of nasal bone were recurrent
aUS findings but a mild borderline microcephaly was seen
in one mosaic case [31-36]. These observations demon-
strated that indicative fetal anomalies for these cytogenomic
syndromes could be identified by ultrasound examination
although genetic heterogeneity for SHFM and Cri du Chat
should be taken into consideration. For all these abnormal
cases, the post-test counseling with detailed genomic infor-
mation helps both the counselors with better phenotype
prediction and the parents for an informed decision.
The clinical impact from recognized compound segmen-
tal deletion and duplication in cases 1, 6, 7 and 8 should be, SHFM and Cri du Chat sydnrome
Etiology References
del(11)(q23) McClelland, 1998 [22]
rofacial clefts. del(11)(q23) Chen, 2001 [23]




del(11)(q23) Bohem, 2006 [25]
rome, 'keel-shaped'
del(11)(q23) Foley, 2007 [26]
ar valve del(11)(q24.1) This report (case#2)
t-foot. Unknown Haak, 2001 [27]
clawlike feet. Unknown Ram, 2009 [28]
th hands and feet,
c.598A>G TP63 gene Simonazzi, 2012 [29]
t, 2 only in
malies in hands.
22q11.2 del, 7q31 del,
8 unknown
Lu, 2014 (10 cases) [30]
del(7)(q11.23q21.3) This report (case#3)
astic cerebellum, large
hal skin edema.
5p- Aoki, 1999 [31]
aly del(5)(p15) Stefanou, 2002 [32]
mos del(5)(p15.1) Chen, 2004 [33]
del(5)(p13) Bakkum 2005 [34]
del(5)(p15.1) Sherer, 2006 [35]
) del(5)(p14) Teoh, 2009 [36]
del(5)(p15.33p15.33) This report (case#5)
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paternal carrier of a balanced translocation in cases 7 and 8
provides genetic explanation for the recurrent spontaneous
abortions. Actually, parental chromosome analyses for case
7 were performed three times in other hospitals; the recip-
rocal translocation in the father, denoted as t(10;11)(q26.13;
q24.1), was missed due to the similar size and light G-band
pattern of the translocated segments. This case indicated
that genomic characterization of prenatal segmental imbal-
ances could facilitate karyotyping recognition of hidden
subtelomeric rearrangements. Interestingly both cases 7
and 8 showed absence of fetal heart at ultrasound examin-
ation which could be explained partially by the shared 11q
deletion for Jacobsen syndrome and partially by compound
effect from other segmental imbalances. The other six
patients (cases 9–14) with hSAB were detected with sim-
ple and compound aneuploids but no other pathogenic
copy number variants. Parental chromosome analyses per-
formed on these six families showed normal findings.
Technically, FISH and QF-PCR have been used for rapid
screening of prenatal aneuploidy but these methods were
limited to a few chromosomal loci [5-7]. MLPA using
aneuploidy probe mix (P095), subtelomeric probe mixes
(P036 and P070) and microdeletion syndromes probe mix
(P245) has been a robust method for rapid prenatal
screening of aneuploidy, unbalanced subtelomeric rear-
rangements and recurrent microdeletions. The turn-
around-time of MLPA screening is usually within one to
three days. However, MLPA screening lacks the genome-
wide coverage and cannot detect copy number changes
outside the represented regions. For example, MLPA
missed the deletion of 7q11.23-q21.3 in case 3 and du-
plication of 3q21.1-q25.1 in case 4. In cases 6, MLPA
detected the 2q deletion but missed the coexisted 2q
duplication. Therefore, MLPA should be used as a rapid
and cost-effective screening for common aneuploids, sub-
telomeric rearrangements and known genomic disorders.
Follow up genome-wide aCGH analysis is strongly recom-
mended to define genomic coordinates for MLPA and
karyotype detected abnormalities and to rule out other
copy number aberrations. Recently, genomic SNP array
has been proposed as a gold standard for prenatal diag-
nosis of fetal ultrasound abnormalities [39], but rapid
replacement of prenatal cytogenetic analysis raised ser-
ious concerns [18]. One major concern is the detection
of variants of unknown significance (VUS), which can
complicate the genetic counseling and add unnecessary
anxiety to the pregnant women. Of the 54 prenatal cases
analyzed by aCGH in this report, no VUS was detected.
The other concern is the high cost of aCGH analysis,
which likely explains the low acceptance rate for further
aCGH analysis in our experience. It is worth noted that
aCGH analysis also has its limitations in the detection
of polyploidy, balanced chromosomal rearrangements,inversions and low level mosaicism. Although routine
chromosome analysis can neither provide the genomic
coordinates for chromosomal abnormalities nor detect
the submicroscopic copy number changes, karyotyping
is still the gold standard for prenatal diagnosis of chromo-
some aneuploids and structural rearrangements.
Conclusions
In summary, aCGH is effective in characterizing chromo-
somal and submicroscopic imbalances. It has been estimated
that approximately 10% of pregnancies with ultrasound-
detected structural anomalies and normal cytogenetic
findings had genomic abnormalities, and 30% of these
abnormalities were recurrent genomic disorders [18]. The
workflow of MLPA, karyotyping and aCGH analysis as
shown in Figure 1 represents a robust and cost-effective ap-
proach for prenatal diagnosis of chromosomal aneuploids,
subtelomeric rearrangements and genomic imbalances. The
MLPA screening results guide focused chromosome ana-
lysis of aneuploids and subtelomeric rearrangements and
aCGH analysis for fine mapping of breakpoints and gene
content of imbalanced regions. Further aCGH analysis on
prenatal cases with indicative clinical findings can help
to detect or rule out other genomic imbalances. This
integrated approach can significantly reduce the number




For the past two years, of the 2509 cases analyzed by
karyotyping and MLPA, numerical chromosomal and struc-
tural abnormalities were noted in 106 (4.2%) and 102 cases
(4.1%), respectively. Of cases with structural chromosomal
abnormalities detected by karyotyping, suspected genomic
abnormalities by MLPA, and indicative findings of aUS,
aMSS, FH and hSAB, pre-test genetic counseling with
detailed information about the advantages and limita-
tions of aCGH was provided. Post-test genetic counsel-
ing for cases with abnormal aCGH results was provided
with detailed genomic findings and evidence-based in-
terpretation. This study was reviewed and approved by
the Ethics Committee of Shenzhen Maternity and Child
Healthcare Hospital and participated patients also provided
written informed consent.
Karyotyping and MLPA analysis
Chromosome analysis was performed on G-band meta-
phases prepared from cultured cells of amniotic fluid (AF),
chorionic villus samples (CVS), and peripheral blood lym-
phocytes according to the laboratory’s standard protocols.
Twenty metaphases were examined for each sample.
Genomic DNA was extracted from AF and CVS using
the chelex-100 (Bio-Rad Laboratories Inc, Hercules, CA,
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NanoDrop spectrophotometer (ND-2000, Thermo Fisher
Scientific Inc., Waltham, MA, USA). For each MLPA
assay, 100 ng of DNA was used following the manufac-
turer’s protocols. The MLPA assays included the SALSA
MLPA P095 aneuploidy probe mix for the detection of ab-
errant copy number of human chromosomes 13, 18, 21, X
and Y, the P036/P070 human subtelomeric probe mix for
the detection of deletions and duplications of subtelomeric
region of each chromosome, the P245 microdeletion
probe mix for 22 regions of 1p36 (OMIM#607872), 2p16
(OMIM#612513), 2q23.1 (OMIM#156200), 2q33 (OMI
M#612313), 3q29 (OMIM#609425), 4p16.3 (OMIM#19
4190), 5p15.2 (OMIM #123450), 5q35 (OMIM#117550),
7q11.23 (OMIM#194050), 8q24.1 (OMIM#150230), 9q22.3,
10p14 (OMIM#601362), 15q11.2 (OMIM#176270, OMI
M#105830), 15q24 (OMIM#613406), 16p13.3 (OMIM#1
80849), 17p13.3 (OMIM#607432, OMIM#247200) 17p11.2
(OMIM#182290), 17q11.2 (OMIM#162200), 17q21 (OMI
M#610443), 22q11.2 (OMIM#188400), 22q13.3 (OMIM#6
06232) and Xq28 (OMIM#312750).Array comparative genomic hybridization (aCGH)
For each sample, 2 μg of genomic DNA was prepared
following the manufacturers protocol for the Agilent
Human Genome CGH microarray 60 K kit (SurePrint
G3 Human CGH 8x60K Microarray Kit) or 180 K kit
(SurePrint G3 Human CGH 4×180K Microarray Kit)
(Agilent Technologies Inc, Santa Clara, CA, USA). This
validated aCGH procedure can achieve 99% sensitivity
and 99% specificity with an analytical resolution determined
by a sliding window of five to seven contiguous oligo-
nucleotides [12]. The base pair designation was based
on the NCBI36/hg18 assembly of the UCSC Human
Genome browser (http://genome.ucsc.edu/).Consent
Written informed consent was obtained from the patient
for participation in this study and publication of this report
and any accompanying images.
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